New Approaches in Continuous BioManufacturing:
|
|
- Hilda Fowler
- 7 years ago
- Views:
Transcription
1 New Approaches in Continuous BioManufacturing: Continuous XD cell cultures (around 100 mln cells/ml) coupled to the Rhobust EBA integrated clarification and purification technology Gerben Zijlstra, PhD Sr. Scientist DSM Biologics, The Netherlands
2 Outline Introduction DSM Biologics DSM XD Technology RHOBUST Expanded Bed Adsorption (EBA) Technology Continuous XD coupled to RHOBUST EBA Principle Continuous XD examples Rhobust EBA on continuous XD harvest Concluding Remarks 1
3 DSM Biologics: Who are we? Part of DSM: A Leading Global Life Sciences & Material Sciences Company Active in 50 countries & 5 continents at over 200 locations 2012 revenue > 9 billion ~23,000 employees DSM Biologics Manufacturing Locations The Netherlands and Australia DSM Biologics Services Contract manufacturing for mammalian cell culture: From development to commercial manufacturing cgmp for all clinical phases & market supply Regulatory support Global reach Proprietary Process Technologies: XD - intensifying upstream process technology RHOBUST - direct capture technology Page 2
4 XD Technology Very high-density mammalian processes Increased bioreactor output & yield per volume 5 15 fold High & Consistent product quality Reduced capital expenditure requirements Lower scale-up risk XD is a registered trademark of DSM Page 3
5 XD : Proprietary Process Intensification Cell Culture Modes Fed Batch Feed concentrate Build up Metabolites Osmo increase Changing environment Reducing cell viabilities Concentrated Harvest batch identification XD Medium Feed Wash out Metabolites No Osmo increase Constant environment High cell viabilities Concentrated Harvest batch identification Perfusion Medium Feed Wash out Metabolites No Osmo increase Constant environment High cell viabilities Dilute harvest Large harvest XD Process Page 4
6 XD : Process Intensification Scale-up - PER.C6 ; Viable cell count L XD reference 50L XD run #1 50L XD run #2 VCD (*10E6 cells/ml) Time (day) Page 5
7 XD scale up Scale-up - PER.C6 ; Product IgG 100 2L XD reference 50L XD run #1 50L XD run # IgG (g/l) Time (day) Page 6
8 XD : Process Intensification Bioreactor Set-up Page 7
9 Preferred retention system: TFF Page 8 Fully disposable, simple operation, robust, flexible filter choice
10 DSM RHOBUST Technology Direct product capture Reduced unit operations From 3 to 1 Higher yields Proven scalability Reduced labor cost & process time Suitable for recombinant proteins, antibodies, vaccines Tungsten carbide incorporated in the agarose bead Page 9
11 RHOBUST Direct Capture Technology Page 10
12 RHOBUST in Action with the XD Harvest Equilibration Cell wash out XD Harvest ~150x10 6 cell/ml First cell breakthrough Wash RHOBUST 1 step! Complete cell breakthrough Elution Post-Protein A intermediate Page 11
13 RHOBUST experiments with XD Harvest Results Fed-batch and classical Protein-A packed bed vs. XD and RHOBUST Protein-A: Yield (%) Purity (%) HCP (ug/mg Mab) DNA (ng/mg Mab) Protein A (ppm) Fed-batch, clarification, Protein-A Packed Bed > 85 > (n=15) (n=2) 9-12 XD, Protein-A RHOBUST > 90 > (n=19) (n=6) 4-14 With high cell viabilities ~10% higher yield HCP, DNA & res.protein A After column in normal range Page 12
14 Outline Introduction DSM Biologics DSM XD Technology RHOBUST Expanded Bed Adsorption (EBA) Technology Continuous XD coupled to RHOBUST EBA Principle Continuous XD examples Rhobust EBA on continuous XD harvest Concluding Remarks 13
15 Continuous XD - Rhobust principle Medium Diluted Waste Stream Waste Product eluate Low ph treatment Waste Elution buffer 2-8 C Product/Cell Bleed Concentrated Product Bleed Tungsten carbide incorporated in the agarose bead XD Bioreactor Cell/Product Bleed Rhobust EBA+Low ph Low ph treated EBA bulk Page 14
16 Continuous XD example 1: Myeloma - IgG Page 15 Continuous XD cultures with Myeloma cells producing highly potent IgG at around 60 mln cells/ml.
17 Continuous XD example 1: Myeloma - IgG Page 16 The Qp (slope of cumulative titer) was constant at maximum Qp.
18 Continuous XD example 2: CHO - IgG Page 17 Continuous XD cultures with CHO cells producing Biosimilar IgG at around 100 mln cells/ml.
19 Continuous XD example 2: CHO - IgG Page 18 The IgG titer in the product was bleed around 2.5 g/l in production phase.
20 Continuous XD example 4: PER.C6 IgG Page 19 Continuous XD with IgG producing PER.C6 cells at around 100 mln cells/ml. IgG titer in the bleed g/l
21 Rhobust EBA example 2: IgG Page 20 An continuous XD bioreactor processed with eight Rhobust EBA runs (6 cell bleeds and 2 final bioreactor harvest loads). Product recovery, averaging at 93% was substantially higher compared to the combination of dead-end filtration and fixed bed Protein-A.
22 Rhobust EBA example 2: IgG Residual DNA and HCP were within normal ranges and comparable to packed bed values. Page 21 Aggregate levels and relative potency were relatively constant throughout the run.
23 22 Concluding remarks Advantages Continuous XD technology coupled to Rhobust EBA USP (Continuous XD cell culture): Functional advantages: Robust, stable performance: Stable growth rate by Cell bleed Very high Productivity: Very high cell density x Maximum Qp No product loss: Bleed = Product! Constant Quality: High viability & Constant environment Operational advantages: Concentrated product flow: Harvest holding point possible DSP (Rhobust EBA Clarification / Capture): Functional advantages: Very high Recovery: Single unit operation, Concentrated product flow Very high Purity: Optimized Rhobust EBA Operational advantages: Easy to use, no column packing, air bubbles and precipitates no problem One step clarification and capture
24 Acknowledgements: R&D Scientist team DSM-B Gerben Zijlstra Olaf Mol Dick Smit Jurjen de Jong Piet den Boer Mark Doeven Erik kremer Henk van Urk Jaco van der Merwe R&D Director Fritjof Linz GMP Process Technologist team Imre Akkerman Maria Perlasca Mark Dressen Harriet van der Molen GMP OPS Manager Esther Heuberger All Technicians involved in this work Page 23
25 Thank you
26 25 Outline Introduction DSM Biologics DSM XD Technology RHOBUST Expanded Bed Adsorption (EBA) Technology Continuous XD coupled to RHOBUST EBA Principle Continuous XD examples Rhobust EBA on continuous XD harvest Concluding Remarks
27 Page 26 Proprietary Technologies vs. Classical Concept Optimize individual Unit Operations Process Intensification & Process Integration
28 Page 27 XD : Process Intensification Bioreactor Set-up Concentrated Product Bleed
29 Page 28 XD : Process Intensification Scaled-up in different 50 L Single Use Bioreactors
30 Scale-up: 200 L XD Results 200 L XD run with CHO cell line performed in PD with 2L satellite run under equal conditions 200 L XD run performed in standard Sartorius STR bioreactor (only increased size side ports) Successful scale-up to equal cell densities (130 mln cells/ml in 200 L) No oxygen or other limitation observed 14,00 12,00 200L XD Biomass corrected titer (Nephelometer) 2L P23037 Titer similar to satellite run > 10 g/l Specific productivity the same Titer (g/l) 10,00 8,00 6,00 4,00 2,00 0,00 0,00 100,00 200,00 300,00 400,00 500,00 600,00 700,00 800,00 900, ,00 IVC Page 29
31 30 Outline Introduction DSM Biologics DSM XD Technology RHOBUST Expanded Bed Adsorption (EBA) Technology Continuous XD coupled to RHOBUST EBA Principle Continuous XD examples Rhobust EBA on continuous XD harvest Concluding Remarks
32 Page 31 Rhobust : In action Elution of concentrated product
33 32 RHOBUST GMP column (30 cm diameter) and MabDirect ProteinA adsorbent GMP EBA column 30cm diameter 20cm - 60cm settled bed EBA level monitoring and control (ultrasound) Low pressure system RFD (variable speed) Disposable flow path UV, flow, conductivity, pressure, temperature, ph using AktaReady Operational MabDirect ProteinA RSF available
34 Rhobust EBA on Cont. XD example 1 Cell density: million cells/ml (viability >80%) Antibody titer: 1.3 g/l Comparison: MabDirect proteina EBA vs. clarification & protein A packed bed chromatography Load ratio: Approx. 22 mg IgG/mL settled bed (both protein A resins) Process Overall yield (%) Purity HP-SEC (%) Buffer use (CV) Process time lab-scale 1 (hours) Process time Manufacturing scale, estimated 2 (hours) Rhobust EBA Clarification & ProteinA packed bed Clarification and chromatographic process (ph treatment, filtration and filling not included) 2 Clarification manufacturing scale will take 6-8 hours (includes dilution, pre-rinse, filtration, post-rinse) 33
35 34 Concluding remarks Advantages RHOBUST technology Operational: Easy to use, no column packing Can deal with air bubbles and precipitated material One step clarification and capture No separate clarification 8-hour time reduction of process time Suitable for other high viscosity feed streams (incl. microbial and yeast). Development and Scale-up Reduced-scale model available (1 cm and 2 cm column + AKTA Explorer) Scalable concept: Pilot scale unit (10 60 cm columns + Rhobust Flex or AKTA Ready) Fully automated GMP unit (10 60 cm colums + AKTA Ready)» 30cm-diameter EBA column with floating piston» EBA level monitoring and control (ultrasound)» Disposable flow path and in process monitoring in place (AKTA Ready) Resins and ligands: Available Resins: MabDirect ProteinA, MabDirect MIMO, FastLine SP Large ligand library (Incl): IMAC, Q, DEAE
36 Continuous XD example 3: PER.C6 Rec. Page 35 Continuous XD culture with PER.C6 cells producing recombinant protein (> 300 kd). Discrete intermittent product bleeds were taken for subsequent DSP
37 Page 36 Principle of the Kremer Method A one step flow-through intermediate purification and polishing procedure, which can optionally be followed by virus filtration. Benefits: One unit operation for 2 chromatography steps Standard dual pump chromatography systems required Product in flow-through, impurities bind ( small resin volumes) No intermediate storage Good removal of aggregates and HCPs The Kremer method has successfully been applied to post Rhobust intermediate yielding very similar purity as classical DSP.
38 Rhobust EBA from Cont. XD example 1 mau OD 280 ph Fractions F3- Load F4 - Wash 1 F5 Wash 2 F6 - Elution F7 - Strip F8 - Cleaning F F3 F4 F5 F6 F7 F Volume (ml)
Process-scale purification of monoclonal antibodies polishing using Capto Q
GE Healthcare Life Sciences Application note 28-937-16 AB Ion exchange chromatography Process-scale purification of monoclonal antibodies polishing using Capto Q Summary Anionic exchange media are an industry
More informationMonoclonal Antibody Production: Building the Platform. Andrew Clutterbuck Eden Biodesign Ltd.
Monoclonal Antibody Production: Building the Platform Andrew Clutterbuck Eden Biodesign Ltd. Questions Questions are encouraged throughout the presentation and can be asked by using the email address provided
More informationEden Biodesign ebook Monoclonal Antibody Production: Building the Platform
Eden Biodesign ebook Monoclonal Antibody Production: Building the Platform CHAPTER 1: Overview CHAPTER 2: Challenges CHAPTER 3: Purification Methodology CHAPTER 4: Results CHAPTER 5: About Eden Biodesign
More informationHigh yield antibody production in a disposable WAVE Bioreactor
High yield antibody production in a Process intensification using perfusion culture Christian Kaisermayer 1, Jianjun Yang 2 1 GE Healthcare Europe GmbH, Vienna, Austria (Christian.Kaisermayer@ge.com),
More informationThe Importance of Developing a High Yield of Product
European Antibody Congress Lyon, 3 rd November 2005 The Importance of Developing a High Yield of Product John Birch, Lonza Biologics plc Monoclonal Antibodies A Success Story Fastest growing segment of
More informationA new, integrated, continuous purification process template for monoclonal antibodies
A new, integrated, continuous purification process template for monoclonal antibodies Alex Xenopoulos* Alison Dupont, Christopher Gillespie, Ajish Potty, Michael Phillips Processing Technologies Merck
More informationBiotechpharma company profile
Biotechpharma company profile October 2013 1 History 2004 Biotechpharma UAB established as a proteomic research company in Vilnius, Lithuania 2005 Company became a member of UK s Northway group, investing
More informationLFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals
LFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals MAbLaunch TM is a joint bioproduction platform combining LFB Biomanufacturing (LFB
More informationSingle Step Clarification & Capture of a Recombinant Protein from E. coli Osmotic Shock by Crossflow Chromatography
www.natrixseparations.com Complex Separations Single Step Clarification & Capture of a Recombinant Protein from E. coli Osmotic Shock by Crossflow Chromatography AN1000 Summary Recombinant Shiga toxin
More informationHow To Develop A Cell Line
Advances in The Development of Biopharmaceuticals The application of modern technologies and services to the development of Biopharmaceutical processes Dr Jonathan H Dempsey Process Science Fellow Invitrogen
More informationContinuous Chromatography for Monoclonal Antibody Purification from Cell Culture Supernatant
Continuous Chromatography for Monoclonal Antibody Purification from Cell Culture Supernatant Massimo Morbidelli Institute for Chemical and Bioengineering, ETH Zurich, Switzerland www.morbidelli.ethz.ch
More informationBioprocessing Media and Buffers Grow with Us
Bioprocessing Media and Buffers Grow with Us Experience Highly experienced media on the selection of standard media as well as development This service packaging, documentation Leading position in single-use
More informationA novel AIEX chromatography medium (resin) to remove IgA and IVIG purification process
A novel AIEX chromatography medium (resin) to remove IgA and IVIG purification Guodong Javier Jia 1, Chor Sing Tan 2, Linus Laurin 3, Henrik Ihre 3, Lili Sui 1 1 Fast Trak China, GE Healthcare Life Sciences,
More informationTrends in Upstream and Downstream Process Development for Antibody Manufacturing
Bioengineering 2014, 1, 188-212; doi:10.3390/bioengineering1040188 OPEN ACCESS bioengineering ISSN 2306-5354 www.mdpi.com/journal/bioengineering Review Trends in Upstream and Downstream Process Development
More informationChallenges in the cgmp Manufacturing of hescs: Lessons Learned from Monoclonal Antibodies
Challenges in the cgmp Manufacturing of hescs: Lessons Learned from Monoclonal Antibodies ISCT 2011 Annual Meeting Rotterdam, The Netherlands May 18 21, 2011 BioProcess Technology Consultants www.bptc.com
More informationMabSelect SuRe. GE Healthcare Life Sciences
GE Healthcare Life Sciences Instructions 11-0026-01 AD Affinity Chromatography MabSelect SuRe MabSelect SuRe is an alkali-tolerant protein A-derived medium for capturing monoclonal antibodies from large
More informationEvaluation of an alkali stable Protein A matrix versus Protein A Sepharose Fast Flow and considerations on process scale-up to 20,000L.
Evaluation of an alkali stable Protein A matrix versus Protein A Sepharose Fast Flow and considerations on process scale-up to 20,000L. Simon C.B. Jones & Martin P. Smith. LONZA, 224 Bath Road, Slough,
More informationApplication Note. Purifying common light-chain bispecific antibodies using MCSGP. Summary
Application Note Purifying common light-chain bispecific antibodies using MCSGP Category Matrix Method Keywords Analytes ID Continuous chromatography, biochromatography Antibodies MCSGP Bispecific antibody,
More informationManufacturing processes for
Single-Use, Continuous- Countercurrent, Multicolumn Chromatography Marc Bisschops, Lynne Frick, Scott Fulton, and Tom Ransohoff Reprinted with permission from BioProcess International 7(6) (June 2009)
More informationLFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals
LFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals MAbLaunch TM is a joint bioproduction platform combining LFB Biomanufacturing (LFB
More informationApplication Note. Separation of three monoclonal antibody variants using MCSGP. Summary
Application Note Separation of three monoclonal antibody variants using MCSGP Category Matrix Method Keywords Analytes ID Continuous chromatography, Biochromatography; FPLC Protein A-purified monoclonal
More informationTECHNICAL BULLETIN. HIS-Select Nickel Affinity Gel. Catalog Number P6611 Storage Temperature 2 8 C
HIS-Select Nickel Affinity Gel Catalog Number P6611 Storage Temperature 2 8 C TECHNICAL BULLETIN Product Description HIS-Select Nickel Affinity Gel is an immobilized metalion affinity chromatography (IMAC)
More informationOverview of Upstream and Downstream Processing of Biopharmaceuticals
Overview of Upstream and Downstream Processing of Biopharmaceuticals Ian Marison Professor of Bioprocess Engineering and Head of School of Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland
More informationBringing Downstream Productivity into Phase with Upstream Antibody Production
Bringing Downstream Productivity into Phase with Upstream Antibody Production Pete Gagnon, Validated Biosystems 3 rd International Monolith Symposium, Portoroz, May 30 June 4, 2008 The need for speed When
More informationAffi-Prep Protein A Matrix Instruction Manual
Affi-Prep Protein A Matrix Instruction Manual Catalog Numbers 156-0005 156-0006 Bio-Rad Laboratories, 2000 Alfred Nobel Dr., Hercules, CA 94547 LIT-230 Rev B Table of Contents Section 1 Introduction...1
More informationImproving GS-CHO Cell Line Selection: Reducing Time to Clinic
Cell Line Development and Engineering 2-6 March 2009, Berlin Improving GS-CHO Cell Line Selection: Reducing Time to Clinic Adrian Haines, 2009 Lonza Biologics plc, Slough, UK Disclaimer Certain matters
More informationAdvances in Biopharmaceutical and Vaccine Manufacturing Plants
Hitachi Review Vol. 62 (2013), No. 4 267 Advances in Biopharmaceutical and Vaccine Manufacturing Plants Sei Murakami, Dr. Eng. Haruo Suzuki Keisuke Shibuya, Dr. Sc. OVERVIEW: The development of innovative
More informationFast Trak Training & Education
GE Healthcare Life Sciences Fast Trak Training & Education Our expertise, your advantage imagination at work Contents General course information General course information 3 Upstream processing Advanced
More informationHiPer Ion Exchange Chromatography Teaching Kit
HiPer Ion Exchange Chromatography Teaching Kit Product Code: HTC001 Number of experiments that can be performed: 5 Duration of Experiment: Protocol: 5-6 hours Storage Instructions: The kit is stable for
More informationMonoclonal antibodies
MAb Contaminant Removal with a Multimodal Anion Exchanger A Platform Step to Follow Protein A Kjell Eriksson, Anders Ljunglöf, Gustav Rodrigo, and Eggert Brekkan Reprinted with permission from BioProcess
More informationHiTrap Heparin HP, 1 ml and 5 ml
Instructions 71-7004-00 AU HiTrap affinity columns HiTrap Heparin HP, 1 ml and 5 ml HiTrap Heparin HP is a prepacked ready to use, column for preparative affinity chromatography. The special design of
More informationCross Flow Filtration Method Handbook
Cross Flow Filtration Method Handbook Page intentionally left blank Table of Contents Table of Contents 1 Introduction... 1.1 What is cross flow filtration?... 1.2 Key features of CFF... 1.3 CFF application
More informationEconomical Approaches to Meeting Global Demand for High Value Biopharmaceuticals
Economical Approaches to Meeting Global Demand for High Value Biopharmaceuticals Howard L. Levine and Susan Dana Jones BPI Europe 2013 Apr 17-18, 2013 Dusseldorf, Germany BioProcess Technology Consultants
More informationRecent advances in the purification of IgM monoclonal antibodies
Recent advances in the purification of IgM monoclonal antibodies Pete Gagnon, Validated Biosystems Frank Hensel, Paul Andrews, Patrys, Ltd. Richard Richieri, Avid BioServices, Inc. 3 rd Wilbio Conference
More informationUse of the ambr 250 in combination with high-throughput design and analysis tools for rapid, scalable USP development
Use of the ambr 250 in combination with high-throughput design and analysis tools for rapid, scalable USP development Authors: Dr Fern Slingsby and Dr Simon Dewar Upstream Process Development FUJIFILM
More informationAccelerating Antibody Process Development: Exploring the Synergies Between Engineered Host Cells and Process Development
Pharma&Biotech Accelerating Antibody Process Development: Exploring the Synergies Between Engineered Host Cells and Process Development James Rance PhD Head of Development Services Singapore Lonza Biologics
More informationBioProcessing J O U R N A L. Trends and Developments in BioProcess Technology. Volume 9 Issue 1 ISSN 1538-8786
A Production of ISBioTech Summer 2010 Issue BioProcessing J O U R N A L Trends and Developments in BioProcess Technology Volume 9 Issue 1 ISSN 1538-8786 Trends & Developments in BioProcess Technology Novel
More informationApplication Note. Increasing the activity of monoclonal antibody isoforms by MCSGP. Summary
Application Note Increasing the activity of monoclonal antibody isoforms by MCSGP Category Matrix Method Keywords Countercurrent chromatography, FPLC Antibodies MCSGP FPLC, Biobetters, MCSGP, countercurrent
More informationA World of Biomanufacturing: Shortages or Global Glut?
A World of Biomanufacturing: Shortages or Global Glut? Howard L. Levine, Ph.D. BioProcess Technology Consultants, Inc. BioProcess International Conference Vienna, Austria May 19-20, 2010 Steady growth
More informationCadence Acoustic Separator
USD3133 Cadence Acoustic Separator Enabling Technology for Continuous Clarification of Batch Cell Culture The Cadence Acoustic Separator (CAS) enables the continuous removal of CHO cells and cell debris
More informationAccelerating drug development to FTIH: Potential of new expression technologies
Accelerating drug development to FTIH: Potential of new expression technologies Lekan Daramola Associate Director Biopharmaceutical Development, Cell Culture & Fermentation Sciences CMC Strategy Forum
More informationIntroduction to Bioprocessing
Introduction to Bioprocessing Cambridge Healthtech Institute Peptalk Palm Springs, CA Presented by Susan Dana Jones and Sheila Magil BioProcess Technology Consultants www.bptc.com BioProcess Technology
More informationNext-Generation Facilities for Monoclonal Antibody Production
Advancing Development & Manufacturing Facilities Next-Generation Facilities for Monoclonal Antibody Production Niels Guldager ELECTRONICALLY REPRINTED FROM JULY 2009 The biopharmaceutical industry faces
More informationValentina Gualato, Ph.D. Process Development Scientist
COMPANY PRESENTATION Quality and Innovation Valentina Gualato, Ph.D. Process Development Scientist MISSION areta international is a biotech company dedicated to the contract development and manufacturing
More informationQbD based Development and Characterization of a Cell Culture Process for Therapeutic Proteins
QbD based Development and Characterization of a Cell Culture Process for Therapeutic Proteins 2015. 06. 09 Green Cross Corp. Green Cross Research Center Yong Jae Kim (YJKIM@greencross.com) Biologics World
More informationWorkshop on process validation
Workshop on process validation CMC Strategy Forum Europe 2013 EBE Process validation satellite session Pragues, 06/05/2013 Kowid Ho Scope / background Process evaluation/validation of biotechnology derived
More informationHow To Test For Cleaning Efficiency With A Predictor 96 Well Filter Plate
GE Healthcare Life Sciences Application note 28-9845-64 AA Process chromatography High-throughput process development for design of cleaning-in-place protocols Cleaning-in-place (CIP) of chromatography
More informationHigh-throughput Process Development with PreDictor Plates
GE Healthcare High-throughput Process Development with PreDictor Plates Principles and Methods imagination at work Handbooks from GE Healthcare GST Gene Fusion System Handbook 18-1157-58 Affinity Chromatography
More informationTHE DEVELOPMENT OF THERAPEUTIC MONOCLONAL ANTIBODY PRODUCTS
THE DEVELOPMENT OF THERAPEUTIC MONOCLONAL ANTIBODY PRODUCTS Table of Contents CHAPTER 1: Overview of Monoclonal Antibody Therapeutics CHAPTER 2: Monoclonal Antibody Discovery Technologies CHAPTER 3: CMC
More informationChoose your optimal tools for protein studies
Protein Purification Choose your optimal tools for protein studies Bacterial Baculoviral Cell free Mammalian Secreted Intracellular High yield Increased solubility Highest purity Highest yield His-tag
More informationEMABling Antibody Production Platform
EMABling Antibody Production Platform An industrial solution for the production of therapeutic antibodies with high cytotoxic activity B IOMANUFACTURING EMABling : A fully integrated development platform
More informationBiomanufacturing Vision for the Future
Biomanufacturing Vision for the Future Shou-Bai Chao, Ph.D. Senior Vice President Global Manufacturing and Technical Operations MedImmune (a Div of AstraZeneca) NIPTE/FDA Research Conference Future of
More informationPOROS CaptureSelect affinity columns for highspeed quantification of IgG Fc fusion proteins
APPLICATION NOTE POROS CaptureSelect affinity chromatography columns POROS CaptureSelect affinity columns for highspeed quantification of IgG Fc fusion proteins Introduction POROS columns, containing highperformance
More informationThe market for therapeutic monoclonal antibodies
PURIFYING THERAPEUTIC MONOCLONAL ANTIBODIES Amit Mehta, Martha Lovato Tse, Jace Fogle, Amy Len, Roshan Shrestha, Nuno Fontes, Bénédicte Lebreton, Bradley Wolk, Robert van Reis Genentech Eliminating the
More informationINSTRUCTIONS 56-1190-98. Edition AC
Sephacryl S-100 High Resolution Sephacryl S-200 High Resolution Sephacryl S-300 High Resolution Sephacryl S-400 High Resolution Sephacryl S-500 High Resolution INSTRUCTIONS Sephacryl High Resolution chromatography
More informationBiopharmaceutical Process Evaluated for Viral Clearance
Authored by S. Steve Zhou, Ph.D. Microbac Laboratories, Inc., Microbiotest Division The purpose of Viral Clearance evaluation is to assess the capability of a manufacturing production process to inactivate
More informationLuca Romagnoli, Ph.D. Business Development Manager
Modelli innovativi di produzione per lo sviluppo di un processo altamente qualitativo di farmaci biologici Luca Romagnoli, Ph.D. Business Development Manager BIOLOGICAL DRUGS - SOURCES Monoclonal antibodies
More informationProtein Synthesis and Purification: Microbial Versus Mammalian Systems
STREAMLINING RECOMBINANT PROTEIN PRODUCTION The pharmaceutical industry is undergoing a deep transformation from small molecule drugs to biologics. Over the last decade, the percentage share of biologic-based
More informationApplication Note USD3013. Monoclonal Antibody Production in Suspension CHO Culture Using Single-Use PadReactor Mini Bioreactor
Application Note USD313 Monoclonal Antibody Production in Suspension CHO Culture Using Single-Use PadReactor Mini Bioreactor Introduction Single use solutions are found in many applications as they offer
More informationBuilding a business case for a fully continuous biomanufacturing platform
Building a business case for a fully continuous biomanufacturing platform Sol Pompe disease Argentina Integrated Continuous Biomanufacturing Jason Walther 23 October 2013 www.genzyme.com Fully continuous
More informationKMS-Specialist & Customized Biosimilar Service
KMS-Specialist & Customized Biosimilar Service 1. Polyclonal Antibody Development Service KMS offering a variety of Polyclonal Antibody Services to fit your research and production needs. we develop polyclonal
More informationData File. Sephadex G-25 media and pre-packed columns. Introduction. Sephadex G-25 Bead structure. Desalting/buffer exchange and gel filtration
P H A R M A C I A B I O T E C H Sephadex G-25 media and pre-packed columns Data File Desalting/buffer exchange and gel filtration Reproducible desalting and buffer exchange in minutes with 90% 100% recovery
More informationGuide to Reverse Phase SpinColumns Chromatography for Sample Prep
Guide to Reverse Phase SpinColumns Chromatography for Sample Prep www.harvardapparatus.com Contents Introduction...2-3 Modes of Separation...4-6 Spin Column Efficiency...7-8 Fast Protein Analysis...9 Specifications...10
More informationSCANTIBODIES Laboratory, Inc. Contract Monoclonal Antibody Production
A Technical Publication of SCANTIBODIES Laboratory, Inc. Volume 1 Number 4 9336 Abraham Way Santee, CA 92071 USA (619) 258-9300 fax (619) 258-9366 www.scantibodies.com SCANTIBODIES Laboratory, Inc. Contract
More informationHis GraviTrap. GE Healthcare. Operation
GE Healthcare Data File 11-0036-90 AB Affinity purification His GraviTrap His GraviTrap is a prepacked, single-use column for purification of histidine-tagged proteins by immobilized metal affinity chromatography
More informationExciting Trends in Bioprocessing
Exciting Trends in Bioprocessing Alfred Doig and Susan Dana Jones, Ph.D. April 20, 2015 BioProcess Technology Consultants, Inc. 12 Gill Street, Suite 5450 Woburn, MA 01801 Exciting Trends in Bioprocessing
More informationApplication Note. USD 2995 (a) High Throughput Regeneration Study on MEP HyperCel Mixed-Mode Sorbent on ScreenExpert RoboColumns u
Application Note USD 2995 (a) High Throughput Regeneration Study on MEP HyperCel Mixed-Mode Sorbent on ScreenExpert RoboColumns u Summary A regeneration study of MEP HyperCel mixed-mode sorbent was conducted
More information1. Introduction to Expanded Bed Adsorption
1. Introduction to Expanded Bed Adsorption This handbook introduces the principles of Expanded Bed Adsorption and serves as a practical guide to the use of STREAMLINE adsorbents and columns available from
More informationEfficient Multi-Well Protein Purification Strategies
Application Note PN 33576 Efficient Multi-Well Protein Purification Strategies Introduction Many tools and techniques are available today for protein purification. Development of a purification process
More informationMab manufacturing today and tomorrow. Reducing risk, reducing cost. Reducing costs, informing decisions, insight for innovation.
Mab manufacturing today and tomorrow. Reducing risk, reducing cost. Reducing costs, informing decisions, insight for innovation. Summary Monoclonal antibodies are expensive to develop and to manufacture.
More informationRESOURCE Q, 1 ml and 6 ml RESOURCE S, 1 ml and 6 ml
GE Healthcare Life Sciences Instructions 71-7146-00 AI Ion Exchange Columns RESOURCE Q, 1 ml and 6 ml RESOURCE S, 1 ml and 6 ml Introduction RESOURCE Q and S are pre-packed columns for separating biomolecules
More informationVaccine Manufacturing Facilities of the Future. Howard L. Levine, Ph.D. Vaccines Europe London, England December 1 2, 2010
Vaccine Manufacturing Facilities of the Future Howard L. Levine, Ph.D. Vaccines Europe London, England December 1 2, 2010 Challenges in the Production of Vaccines Different technology platforms make it
More informationAurum Ion Exchange Mini Kits and Columns. Instruction Manual
Aurum Ion Exchange Mini Kits and Columns Instruction Manual Catalog # 732-6710 Aurum AEX Mini Kits, 2 pk 732-6705 Aurum AEX Mini Kits, 10 pk 732-6706 Aurum AEX Mini Columns, 25 pk 732-6707 Aurum AEX Mini
More informationMLX BCG Buccal Cell Genomic DNA Extraction Kit. Performance Characteristics
MLX BCG Buccal Cell Genomic DNA Extraction Kit Performance Characteristics Monolythix, Inc. 4720 Calle Carga Camarillo, CA 93012 Tel: (805) 484-8478 monolythix.com Page 2 of 9 MLX BCG Buccal Cell Genomic
More informationApplication Guide... 2
Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue Application Guide... 2 I. Description... 2 II. Product Components... 2 III. Materials to be Supplied
More informationXPure. Simulated Moving Bed. www.xendo.com. System for Chromatography and Ion exchange applications. Better solutions for your purification needs
XPure Simulated Moving Bed System for Chromatography and Ion exchange applications Better solutions for your purification needs www.xendo.com ... is an independent engineering and consulting company, was
More informationTechnology Transfer of CMC Activities for MAb Manufacturing. 2010 ge healthcare (www.gelifesciences.com)
M a n u f a c t u r i n g OPERATIONS Technology Transfer of CMC Activities for MAb Manufacturing by Patricia Seymour, Susan Dana Jones, Howard L. Levine With combined 2009 revenues estimated to be over
More informationTechnologies for Monoclonal Antibody Production
Technologies for Monoclonal Antibody Production First we help you bridge the distance between upstream and downstream. Then we help you shorten it. Monoclonal antibodies for therapeutic, diagnostic and
More informationTriskel: a strategic consulting firm for biopharmaceutical companies
BioStart : Manufacturing and operations in Biotech Strategic stakes and technology evolution in recombinant protein production APFL May 14 th, 2009 François LAWNY Triskel Integrated Services Geneva, Switzerland
More informationChromatin Immunoprecipitation
Chromatin Immunoprecipitation A) Prepare a yeast culture (see the Galactose Induction Protocol for details). 1) Start a small culture (e.g. 2 ml) in YEPD or selective media from a single colony. 2) Spin
More informationTransgenic technology in the production of therapeutic proteins
Transgenic technology in the production of therapeutic proteins Transgenic technology represents a new generation of biopharmaceutical production system to meet the medical needs of the new millennium.
More informationHis Mag Sepharose excel. Ni Sepharose excel. HisTrap excel. gelifesciences.com
Data file 29-168-49 AC His Mag Sepharose excel Ni Sepharose excel HisTrap excel Affinity chromatography His Mag Sepharose excel and Ni Sepharose excel (Fig 1) are immobilized metal ion affinity chromatography
More informationCustomer Application Brief. Filtration Processes Applied in Therapeutic Monoclonal Antibody Production. Bioprocess, Biologicals, & Pharmaceutical
Customer Application Brief Bioprocess, Biologicals, & Pharmaceutical Filtration Processes Applied in Therapeutic Monoclonal Antibody Production Introduction Monoclonal antibodies were among the first biotechnology
More informationHigh-Throughput 3-D Chromatography Through Ion Exchange SPE
High-Throughput 3-D Chromatography Through Ion Exchange SPE Application Note 205 Luke Roenneburg and Alan Hamstra (Gilson, Inc.) Introduction 2-dimensional (2-D) separation is the separation of a sample
More informationPurification of GST-tagged Proteins
Purification of GST-tagged Proteins User Manual Protino GST/4B Columns 1 ml Protino GST/4B Columns 5 ml January 2010 / Rev. 01 MACHEREY-NAGEL MN Table of contents 1 Components 4 1.1 Kit contents and storage
More informationOasis HLB Cartridges and 96-Well Plates
CONTENTS I. INTRODUCTION II. SAMPLE PRE-TREATMENT a. Biological Samples b. Solid Samples: Soil, Whole Foods, Tissue c. Aqueous Samples: Water, Beverages d. Non-Aqueous Liquid III. SOLID PHASE EXTRACTION
More informationTransforming a ChromLab Software 2-D Purification Template into an Automated Multidimensional (Multi-D) Purification Workflow An Instructional Guide
Transforming a ChromLab Software -D Purification Template into an Automated Multidimensional (Multi-D) Purification Workflow An Instructional Guide Instructional Guide Chromatography Bulletin 675 ChromLab
More informationBlue Sepharose 6 Fast Flow
GE Healthcare Life Sciences Instructions 71-7055-00 AI Affinity chromatography Blue Sepharose 6 Fast Flow Blue Sepharose 6 Fast Flow is Cibacron Blue 3G covalently attached to the Sepharose 6 Fast Flow
More informationClassic Immunoprecipitation
292PR 01 G-Biosciences 1-800-628-7730 1-314-991-6034 technical@gbiosciences.com A Geno Technology, Inc. (USA) brand name Classic Immunoprecipitation Utilizes Protein A/G Agarose for Antibody Binding (Cat.
More informationSYNERGISTIC APPLICATION OF ADVANCED PRIMARY AND SECONDARY WASTEWATER TREATMENT SYSTEMS
SYNERGISTIC APPLICATION OF ADVANCED PRIMARY AND SECONDARY WASTEWATER TREATMENT SYSTEMS Published in Water and Waste Digest membrane issue, November 2008 Miroslav Colic; Chief Scientist, Clean Water Technology
More informationManufacturing process of biologics
Manufacturing process of biologics K. Ho Afssaps, France 2011 ICH International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use 2011 ICH 1 Disclaimer:
More informationMethod Development for Size-Exclusion Chromatography of Monoclonal Antibodies and Higher Order Aggregates
Method Development for Size-Exclusion Chromatography of Monoclonal Antibodies and Higher Order Aggregates Paula Hong and Kenneth J. Fountain Waters Corporation, 34 Maple St., Milford, MA, USA APPLICATION
More informationWastewater Reuse. Typical treated wastewater is:
Wastewater Reuse Most metal finishing industries have in-house wastewater treatment to economically dispose of the acids, alkali, oils, and dissolved metals in the rinse water and occasional tank solution
More informationMustang Q XT Chromatography Capsules
USD 2599 Mustang Q XT Chromatography Capsules High Throughput, Scalable, and Reusable Ion Exchange Membrane Chromatography Meeting Process Demands for Scalability and Economy The use of ion exchange chromatography
More informationGuidance for Industry. Monoclonal Antibodies Used as Reagents in Drug Manufacturing
Guidance for Industry Monoclonal Antibodies Used as Reagents in Drug Manufacturing U.S. Department of Health and Human Services Food and Drug Administration enter for Drug Evaluation and Research (DER)
More informationPOROS CaptureSelect affinity columns for rapid, small-scale purification and sample preparation of recombinant proteins
APPLICATION NOTE POROS CaptureSelect affinity chromatography columns POROS CaptureSelect affinity columns for rapid, small-scale purification and sample preparation of recombinant proteins Introduction
More informationGenomic DNA Extraction Kit INSTRUCTION MANUAL
Genomic DNA Extraction Kit INSTRUCTION MANUAL Table of Contents Introduction 3 Kit Components 3 Storage Conditions 4 Recommended Equipment and Reagents 4 Introduction to the Protocol 4 General Overview
More informationAspects of industrial purification of peptides using large-scale chromatography. Lars Andersson and Jonas Persson
Aspects of industrial purification of peptides using large-scale chromatography Introduction By Lars Andersson and Jonas Persson PolyPeptide Laboratories (Sweden) AB PO Box 30089 SE-200 61 LIMHAMN SWEDEN
More informationC 5. chemical development contract research custom synthesis cgmp API manufacturing commercial production. Welcome to
C 5 chemical development contract research custom synthesis cgmp API manufacturing commercial production Welcome to ChemCon Company profile Company profile ChemCon offers outstanding chemical services
More informationTHE His Tag Antibody, mab, Mouse
THE His Tag Antibody, mab, Mouse Cat. No. A00186 Technical Manual No. TM0243 Update date 01052011 I Description.... 1 II Key Features. 2 III Storage 2 IV Applications.... 2 V Examples - ELISA..... 2 VI
More information